Type2diabetes clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Type 2 Diabetes and Blood Brain Barrier Improvement
Sorry, not yet accepting patients
The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.
at UCLA
Our lead scientists for Type2diabetes research studies include Rajesh Kumar, PhD.
Last updated: